Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

The class II tumor-suppressor gene RARRES3 is expressed in B cell lymphocytic leukemias and down-regulated with disease progression

Leukemia volume 15, pages 1521–1526 (2001)Cite this article

Abstract

The molecular pathogenesis of B cell chronic lymphocytic leukemia (B-CLL), the most common form of leukemia, remains unknown. We have used the mRNA differential display technique to analyze genes that may be involved in the development/progression of B-CLL. We have identified the tumor suppressor retinoic acid receptor responder 3 (RARRES3) as a B-CLL-related gene. RARRES3 maps to chromosome band 11q23, a region frequently deleted in lymphoproliferative disorders. To assess the potential involvement of RARRES3 in leukemogenesis, we examined 24 cases of B-CLL, 10 of acute lymphocytic leukemia (ALL) and five related cell lines by RT-PCR and sequence analyses. We report a correlation between RARRES3 down-regulation and B-CLL progression. We also found decreased RARRES3 gene levels in ALL cases and in the five cell lines studied. We did not find mutations in any of the leukemia samples assayed, including those with 11q23 deletion. These results indicate that RARRES3 may play a role in B-CLL progression.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Gale RP, Foon KA . Biology of chronic lymphocytic leukemia Semin Hematol 1987 24: 209–229

    CAS  PubMed  Google Scholar 

  2. Kipps TJ . Chronic lymphocytic leukemia Curr Opin Hematol 2000 7: 223–234

    Article  CAS  Google Scholar 

  3. Moore JS, Friedman DF, Silberstein LE, Besa EC, Nowell PC . Clinical heterogeneity reflects biologic diversity in chronic lymphocytic leukemia Crit Rev Oncol Hematol 1995 20: 141–164

    Article  CAS  Google Scholar 

  4. Rozman C, Montserrat E . Chronic lymphocytic leukemia N Engl J Med 1995 333: 1052–1057

    Article  CAS  Google Scholar 

  5. Fegan C, Robinson H, Thompson P, Whittaker JA, White D . Karyotypic evolution in CLL: identification of a new sub-group of patients with deletions of 11q and advanced progessive disease Leukemia 1995 9: 2003–2008

    CAS  PubMed  Google Scholar 

  6. Larramendy ML, Siitonen SM, Zhu Y, Hurme M, Vilpo L, Vilpo JA, Knuutila S . Optimized mitogen stimulation induces proliferation of neoplastic B cells in chronic lymphocytic leukemia: significance for cytogenetic analysis. The Tampere CLL group Cytogenet Cell Genet 1998 82: 215–221

    Article  CAS  Google Scholar 

  7. Stilgenbauer S, Liebisch P, James MR, Schröder M, Schlegelberger B, Fischer K, Bentz M, Lichter P, Döhner H . Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-q23.1 in lymphoproliferative disorders Proc Natl Acad Sci USA 1996 93: 11837–11841

    Article  CAS  Google Scholar 

  8. Karhu R, Knuutila S, Kallioniemi OP, Siltonen S, Aine R, Vilpo L, Vilpo J . Frequent loss of the 11q14-24 region in chronic lymphocytic leukemia: a study by comparative genomic hybridization. Tampere CLL group Genes Chromosom Cancer 1997 19: 286–290

    Article  CAS  Google Scholar 

  9. Döhner H, Stilgenbauer S, Döhner K, Bentz M, Lichter P . Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis J Mol Med 1999 77: 266–281

    Article  Google Scholar 

  10. Zhu Y, Monni O, El-Rifai W, Siitonen SM, Vilpo L, Vilpo J, Knuutila S . Discontinuous deletions at 11q23 in B cell chronic lymphocytic leukemia Leukemia 1999 13: 708–712

    Article  CAS  Google Scholar 

  11. Döhner H, Stilgenbauer S, James MR, Benner A, Weilguni T, Bentz M, Fischer K, Hunstein W, Lichter P . 11q deletions identify a new subset of B cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis Blood 1997 89: 2516–2522

    PubMed  Google Scholar 

  12. Corcoran MM, Sangfelt O, Kapanadze B, Makeevaa N, Ibbotson RE, Baranova A, Zabarovsky E, Merup M, Jansson O, Gahrton G, Einhorn S, Grander D, Oscier DG . Characterisation of a candidate tumor suppressor gene LEU2B located at 13q14.3 in chronic lymphocytic leukemia Blood 2000 96: (Suppl. 1) 702a

    Google Scholar 

  13. Starostik P, Manshouri T, O'Brien S, Freireich E, Kantarjian H, Haidar M, Lerner S, Keating M, Albitar M . Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia Cancer Res 1998 58: 4552–4557

    CAS  PubMed  Google Scholar 

  14. Bullrich F, Rasio D, Kitada S, Starostik P, Kipps T, Keating M, Albitar M, Reed JC, Croce CM . ATM mutations in B-cell chronic lymphocytic leukemia Cancer Res 1999 59: 24–27

    CAS  PubMed  Google Scholar 

  15. Cordone I, Masi S, Mauro FR, Soddu S, Morsilli O, Valentini T, Vegna ML, Guglielmi C, Mancini F, Giuliacci S, Sacchi A, Mandelli F, Foa R . p53 expression in B-cell chronic lymphocytic leukemia: a marker of disease progression and poor prognosis Blood 1998 91: 4342–4349

    CAS  PubMed  Google Scholar 

  16. Padua RA, McKenna S, Butler PC, Williams-Gregory D, Jordan D, Smith M, White D, Whittaker J, Bentley P, Burnett AK, Jacobs A . Identification of retinoic acid receptor alpha (RARα) gene rearrangements in leukaemias: cloning of a novel RARα-PLZF (promyelocytic leukaemia zinc finger) fusion in a patient with chronic lymphocytic leukaemia Blood 1995 86: (Suppl. 1) 34a

    Google Scholar 

  17. Parrado A, West R, Jordan D, Bastard C, McKenna S, Whittaker JA, Bentley P, White D, Chomienne C, Padua RA . Alterations of the retinoic acid receptor alpha (RAR alpha) gene in myeloid and lymphoid malignancies Br J Haematol 1999 104: 738–741

    Article  CAS  Google Scholar 

  18. Liang P, Pardee AB . Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction Science 1992 257: 967–971

    Article  CAS  Google Scholar 

  19. DiSepio D, Ghosn C, Eckert RL, Deucher A, Robinson N, Duvic M, Chandraratna RAS, Nagpal S . Identification and characterization of a retinoid-induced class II tumor suppressor/growth regulatory gene Proc Natl Acad Sci USA 1998 95: 14811–14815

    Article  CAS  Google Scholar 

  20. Binet JL, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J, Vaugier G, Potron G, Colona P, Oberling F, Thomas M, Tchernia G, Jacquillat C, Boivin P, Lesty C, Duault MT, Monconduit M, Belabbes S, Gremy F . A new prognostic clasification of chronic lymphocytic leukemia derived from a multivariate analysis Cancer 1981 48: 198–206

    Article  CAS  Google Scholar 

  21. Rai KK, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternak BS . Clinical staging of chronic lymphocytic leukemia Blood 1975 46: 219–234

    CAS  PubMed  Google Scholar 

  22. De la Fuente MT, Casanova B, Garcia-Gila M, Silva A, Garcia-Pardo A . Fibronectin interaction with α4β1 integrin prevents apoptosis in B-cell chronic lymphocytic leukemia: correlation with Bcl-2 and Bax Leukemia 1999 13: 266–274

    Article  CAS  Google Scholar 

  23. Mitelman F . ISCN 1995: an International System for Cytogenetic Nomenclature Karger: Basel 1995

    Google Scholar 

  24. Rasio D, Negrini M, Maneti G, Dragani TA, Croce C . Loss of heterozygosity at chromosome 11q in lung adenocarcinoma: identification of three independent regions Cancer Res 1995 55: 3988–3991

    CAS  PubMed  Google Scholar 

  25. Mitelman F . Catalog of Chromosome Aberrations in Cancer 6th edn Alan R Liss: New York 1996

    Google Scholar 

  26. Monni O, Oinonen R, Elonen E, Franssila K, Teerenhovi L, Joensuu H, Knuutila S . Gain of 3q and deletion of 11q22 are frequent aberrations in mantle cell lymphoma Genes Chromosom Cancer 1998 21: 298–307

    Article  CAS  Google Scholar 

  27. Monni O, Zhu Y, Franssila K, Oinonen R, Hoglund P, Elonen E, Joensuu H, Knuutila S . Molecular characterization of deletion at 11q22.1–23.3 in mantle cell lymphoma Br J Haematol 1999 104: 665–671

    Article  CAS  Google Scholar 

  28. Zhu Y, Monni O, Franssila K, Elonen E, Vilpo J, Joensuu H, Knuutila S . Deletions at 11q23 in different lymphoma subtypes Haematologica 2000 85: 908–912

    CAS  PubMed  Google Scholar 

  29. Laport GF, Larson RA . Treatment of adult acute lymphoblastic leukemia Semin Oncol 1997 24: 70–82

    CAS  PubMed  Google Scholar 

  30. Rice JC, Ozcelik H, Maxeiner P, Andrulis I, Futscher BW . Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens Carcinogenesis 2000 21: 1761–1765

    Article  CAS  Google Scholar 

  31. Corn PG, Kuerbitz SJ, van Noesel MM, Esteller M, Compitello N, Baylin SB, Herman JG . Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5′ CpG island methylation Cancer Res 1999 59: 3352–3356

    CAS  PubMed  Google Scholar 

  32. Baur AS, Shaw P, Burri N, Delacretaz F, Bosman FT, Chaubert P . Frequent methylation silencing of p15(INK4b) (MTS2) and p16(INK4a) (MTS1) in B cell and T cell lymphomas Blood 1999 94: 1773–17781

    CAS  PubMed  Google Scholar 

  33. Drexler HG . Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia–lymphoma cells Leukemia 1998 12: 845–859

    Article  CAS  Google Scholar 

  34. Warnecke PM, Bestor TH . Cytosine methylation and human cancer Curr Opin Oncol 2000 12: 68–73

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by grants SAF97-0064-CO3-02 (to AGP) and SAF97-0064-CO3-03 (to AS) from the Comisión Interministerial de Ciencia y Tecnología (CICYT); 08.1/0028/99 (to AGP) and 08.1/012/97 (to AS and AGP) from the Comunidad Autónoma de Madrid (CAM). B Casanova, MT de la Fuente and L Sanz were supported by fellowships from CAM; M García-Gila was supported by a fellowship from CICYT. We thank Drs Felipe Prosper and M José Terol (Hospital Clinico Universitario, Valencia, Spain) and Dr Ernesto Roldán (Hospital Ramón y Cajal, Madrid, Spain) for some of the samples and clinical data of B-CLL patients; Dr Santiago Rodríguez de Córdoba for critical reading of the manuscript and Ms Mercedes Hemández del Cerro for excellent technical assistance.

Author information

Authors and Affiliations

  1. Departamento de Inmunología, Centro de Investigaciones Biológicas, CSIC, Madrid, Spain

    B Casanova, MT de la Fuente, M Garcia-Gila, L Sanz, A Silva & A Garcia-Pardo

  2. Servicio de Hematología, Hospital Universitario Clínica Puerta de Hierro, Madrid, Spain

    JA Garcia-Marco

Authors
  1. B Casanova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. MT de la Fuente
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Garcia-Gila
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L Sanz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. JA Garcia-Marco
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A Garcia-Pardo
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Casanova, B., de la Fuente, M., Garcia-Gila, M. et al. The class II tumor-suppressor gene RARRES3 is expressed in B cell lymphocytic leukemias and down-regulated with disease progression. Leukemia 15, 1521–1526 (2001). https://doi.org/10.1038/sj.leu.2402243

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402243

Keywords

This article is cited by

Search

Advanced search

Quick links